Nimotuzumab

Nimotuzumab Suppliers list
Company Name: Wuhan Topule Biopharmaceutical Co., Ltd
Tel: +8618327326525
Email: masar@topule.com
Products Intro: Product Name:Nimotuzumab
CAS:780758-10-3
Purity:98%+ Package:100mg;1g;500g Remarks:Topule Company operates with integrity and has its own laboratory, which supports packaging and customization. Payment will be made after the product has passed third-party testing
Company Name: Wuhan Jingkang en Biomedical Technology Co., Ltd
Tel: +8613720134139
Email: orders@jknbiochem.com
Products Intro: Product Name:Nimotuzumab
CAS:780758-10-3
Purity:0.98 Package:10G:100G
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Products Intro: Product Name:Nimotuzumab
CAS:780758-10-3
Purity:95% Package:2mg;5mg;10mg
Company Name: Wuhan Topule  
Tel: +86-02787215551 +86-19945035818
Email: 2936752263@qq.com
Products Intro: Product Name:Nimotuzumab
Purity:98% hplc lcms Package:5MG;10MG;50MG;100MG,1G,5G, 5KG;1KG
Company Name: cjbscvictory  
Tel: 13348960310 13348960310
Email: 3003867561@qq.com
Products Intro: Product Name:Nimotuzumab
CAS:780758-10-3
Purity:98% Package:5mg;10mg;20mg;50mg;100mg;200mg
Nimotuzumab Basic information
Product Name:Nimotuzumab
Synonyms:
CAS:780758-10-3
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Nimotuzumab Structure
Nimotuzumab Chemical Properties
storage temp. Store at -20°C
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Nimotuzumab Usage And Synthesis
DescriptionNimotuzumab(Taixinsheng) is a biologically targeted drug that acts on the epidermal growth factor receptor (EGFR) on the surface of tumor cells, inhibiting the proliferation and differentiation of tumor cells. It has the advantages of low reaction and good safety.
Suitable for head and neck tumors, gliomas, colorectal cancer, pancreatic cancer, esophageal cancer, liver cancer, non-small cell lung cancer and other solid tumors.
PharmacologyNimotuzumab, as the first humanized monoclonal antibody in my country, can competitively bind to EGFR and block its conduction pathway, thereby inhibiting tumor cell proliferation and tumor angiogenesis, thereby enhancing the efficacy of radiotherapy and chemotherapy.
targetEGFR
Nimotuzumab Preparation Products And Raw materials
Tag:Nimotuzumab(780758-10-3) Related Product Information
Panitumumab Trastuzumab Abciximab Matuzumab Pertuzumab Batoclimab Nipocalimab Rozanolixizumab OMALIZUMAB Aprutumab